jcm-logo

Journal Browser

Journal Browser

Pharmacotherapy of Mental Diseases: Latest Developments

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Mental Health".

Deadline for manuscript submissions: 20 April 2026 | Viewed by 6

Special Issue Editors


E-Mail Website
Guest Editor
Neuroscience Department, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania
Interests: psychology; mental health; behavioral medicine; pharmacotherapy; psychopathology; psychotherapy

E-Mail Website
Guest Editor
Neuroscience Department, "Victor Babes" University of Medicine and Pharmacy, 300041 Timisoara, Romania
Interests: medicine; public health; psychopathology; pediatric neuropsychiatry; pharmacology

Special Issue Information

Dear Colleagues,

I am pleased to invite you to contribute to the following Special Issue entitled “Pharmacotherapy of Mental Diseases: Latest Developments”, which aims to highlight recent advances and interdisciplinary approaches in the pharmacological treatment of psychiatric and neuropsychiatric conditions.

Mental health disorders, such as depression, anxiety, bipolar disorder, schizophrenia and neurodevelopmental syndromes, continue to affect millions of people globally, with a significant impact on quality of life and psychological well-being.

Pharmacotherapy plays a crucial role in their management, but significant challenges remain, including treatment resistance, side effects, non-adherence to treatment and the need for individualized approaches.

This Special Issue aims to explore how pharmacotherapy, when combined with or used as an alternative to psychotherapy and brain stimulation techniques, can contribute to improved outcomes. We are particularly interested in research that supports novel interventions, enhances our clinical understanding of these diseases and promotes personalized treatment in mental illness.

We welcome contributions that cover a wide range of topics, including but not limited to the following: combination therapies and augmentation strategies; long-term efficacy, tolerability, and safety profiles; pharmacotherapy in special populations (children, elderly, pregnant women); considerations in psychiatric pharmacotherapy; empirical research on treatment efficacy and outcomes; reviews and papers on intervention models; and studies on comorbidity and transdiagnostic approaches.

We welcome the submission of both empirical studies and papers, and look forward to receiving your contributions to this important and timely collection.

Prof. Dr. Lavinia Maria Hogea
Prof. Dr. Laura Alexandra Nussbaum
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • brain stimulation
  • mental health
  • novel intervention
  • pharmacotherapy
  • psychotherapy
  • quality of life
  • psychologi-cal well-being
  • treatment personalization in mental diseases

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop